Minimise Regulatory Risk in China with NSF’s Proven Compliance Framework

Regulatory missteps in China can lead to costly delays, rejected applications, or even market withdrawal. NSF’s China Services Brochure presents a structured, risk-based approach to ensure your medical device meets NMPA standards—first time, every time.

Our compliance framework covers:

• Accurate classification and clinical pathway selection
• Gap analysis and documentation alignment with Chinese standards
• Proactive deficiency letter response strategies
• Post-market risk evaluation and AE reporting
• Renewal and change registration planning

Why it matters:

China’s regulatory environment is unique. NSF’s localised expertise and hands-on support help you avoid pitfalls and maintain uninterrupted market access.